Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Baricitinib is effective and safe for treating severe alopecia areata.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Erlotinib can cause nonscarring hair loss and itchy skin.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Baricitinib is effective and safe for treating alopecia areata.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Erlotinib can cause excessive eyelash growth.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.